• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    AbbVie Inc. (ABBV)

    -NYSE
    63.98 Down 0.53(0.82%) Aug 28, 4:04PM EDT
    |After Hours : 64.00 Up 0.02 (0.03%) Aug 28, 6:42PM EDT
    Add to Portfolio
    Prev Close:64.51
    Open:63.91
    Bid:63.91 x 200
    Ask:64.45 x 300
    1y Target Est:76.93
    Beta:1.57619
    Earnings Date:Oct 29 - Nov 2 (Est.)
    Day's Range:63.44 - 64.78
    52wk Range:52.06 - 71.60
    Volume:7,316,411
    Avg Vol (3m):9,357,360
    Market Cap:105.90B
    P/E (ttm):49.75
    EPS (ttm):1.29
    Div & Yield:2.04 (3.06%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ABBVDown 0.82%105.90B
    MRKUp 0.76%155.96B
    PFEDown 1.80%201.43B

    Key Statistics

    Forward P/E (1 yr):12.72
    P/S (ttm):5.09
    Ex-Dividend Date:13-Jul-15

    Analysts

    Annual EPS Est (Dec-15) :4.26
    Quarterly EPS Est (Sep-15) :1.06
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):0.88

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback